top of page

January 2023



VivaVision and Everads Collaborate to Develop Durable and Effective Therapies for Retinal Diseases. Delivery of VivaVision's best-in-class molecules via the suprachoroidal space using Everads' technology is expected to lead to novel treatments for retinal diseases.




Comments


bottom of page